Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

Similar articles for PubMed (Select 22607910)

1.

Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.

Rosenzweig KE, Zauderer MG, Laser B, Krug LM, Yorke E, Sima CS, Rimner A, Flores R, Rusch V.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1278-83. doi: 10.1016/j.ijrobp.2011.09.027. Epub 2012 May 18.

2.

Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.

Chance WW, Rice DC, Allen PK, Tsao AS, Fontanilla HP, Liao Z, Chang JY, Tang C, Pan HY, Welsh JW, Mehran RJ, Gomez DR.

Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):149-56. doi: 10.1016/j.ijrobp.2014.08.343. Epub 2014 Oct 25.

PMID:
25442335
3.

Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.

Allen AM, Czerminska M, Jänne PA, Sugarbaker DJ, Bueno R, Harris JR, Court L, Baldini EH.

Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):640-5.

PMID:
16751058
4.

Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.

Patel PR, Yoo S, Broadwater G, Marks LB, Miles EF, D'Amico TA, Harpole D, Kelsey CR.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):362-8. doi: 10.1016/j.ijrobp.2011.11.057.

PMID:
22516382
5.

Intensity-modulated radiation therapy with simultaneous integrated boost in unresected left-sided pleural mesothelioma: a case report.

Cilla S, Digesú C, Silvano G, Macchia G, Massaccesi M, Deodato F, Padula GD, Fidanzio A, Piermattei A, Morganti AG.

Tumori. 2010 Jul-Aug;96(4):618-22.

6.

Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung.

Minatel E, Trovo M, Polesel J, Rumeileh IA, Baresic T, Bearz A, Del Conte A, Franchin G, Gobitti C, Drigo A, Dassie A, Pagan V, Trovo MG.

J Thorac Oncol. 2012 Dec;7(12):1862-6. doi: 10.1097/JTO.0b013e318272601f.

PMID:
23154558
7.

[Value of tomotherapy in malignant pleural mesothelioma: first clinical results].

Giraud P, Sylvestre A, Lisbona A, Zefkili S, Bonnette P, Le Pimpec Barthes F, Michaud JL, Perigaud C, Mahé MA.

Rev Mal Respir. 2011 May;28(5):609-17. doi: 10.1016/j.rmr.2011.03.003. Epub 2011 Apr 3. French.

PMID:
21645831
8.

Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.

Kristensen CA, Nøttrup TJ, Berthelsen AK, Kjaer-Kristoffersen F, Ravn J, Sørensen JB, Engelholm SA.

Radiother Oncol. 2009 Jul;92(1):96-9. doi: 10.1016/j.radonc.2009.03.011. Epub 2009 Apr 11.

PMID:
19364621
9.

Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.

Minatel E, Trovo M, Polesel J, Baresic T, Bearz A, Franchin G, Gobitti C, Rumeileh IA, Drigo A, Fontana P, Pagan V, Trovo MG.

Lung Cancer. 2014 Jan;83(1):78-82. doi: 10.1016/j.lungcan.2013.10.013. Epub 2013 Oct 27.

PMID:
24216141
10.

A feasibility study of induction pemetrexed plus cisplatin followed by pleurectomy/decortication aimed at macroscopic complete resection for malignant pleural mesothelioma.

Shimokawa M, Hasegawa S, Fukuoka K, Okada M, Yokoi K, Tanaka F, Yamanaka T, Daimon T, Nakano T.

Jpn J Clin Oncol. 2013 May;43(5):575-8. doi: 10.1093/jjco/hyt035. Epub 2013 Mar 17.

11.

Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma.

Gupta V, Mychalczak B, Krug L, Flores R, Bains M, Rusch VW, Rosenzweig KE.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1045-52. Epub 2005 Jul 28.

PMID:
16054774
12.

A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the "SMART" approach for resectable malignant pleural mesothelioma.

Cho BC, Feld R, Leighl N, Opitz I, Anraku M, Tsao MS, Hwang DM, Hope A, de Perrot M.

J Thorac Oncol. 2014 Mar;9(3):397-402. doi: 10.1097/JTO.0000000000000078.

PMID:
24445595
13.

Current readings: improvements in intensity-modulated radiation therapy for malignant pleural mesothelioma.

Rosenzweig KE.

Semin Thorac Cardiovasc Surg. 2013 Autumn;25(3):245-50. doi: 10.1053/j.semtcvs.2013.10.004. Epub 2013 Oct 18. Review.

PMID:
24331147
14.

Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access program.

Jänne PA, Wozniak AJ, Belani CP, Keohan ML, Ross HJ, Polikoff JA, Mintzer DM, Ye Z, Monberg MJ, Obasaju CK; Pemetrexed expanded access program investigators.

J Thorac Oncol. 2006 Jul;1(6):506-12. Erratum in: J Thorac Oncol. 2006 Sep;1(7):621.

PMID:
17409909
15.

Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.

Krug LM, Pass HI, Rusch VW, Kindler HL, Sugarbaker DJ, Rosenzweig KE, Flores R, Friedberg JS, Pisters K, Monberg M, Obasaju CK, Vogelzang NJ.

J Clin Oncol. 2009 Jun 20;27(18):3007-13. doi: 10.1200/JCO.2008.20.3943. Epub 2009 Apr 13.

16.

Pemetrexed in malignant pleural mesothelioma and the clinical outcome.

Knuuttila A, Salomaa ER, Saikkonen S, Hurme S, Salo J.

Clin Respir J. 2012 Apr;6(2):96-103. doi: 10.1111/j.1752-699X.2011.00252.x. Epub 2011 Jul 6.

PMID:
21651743
17.

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P.

J Clin Oncol. 2003 Jul 15;21(14):2636-44.

PMID:
12860938
18.

Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma.

Rimner A, Spratt DE, Zauderer MG, Rosenzweig KE, Wu AJ, Foster A, Yorke ED, Adusumilli P, Rusch VW, Krug LM.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):394-401. doi: 10.1016/j.ijrobp.2014.05.032. Epub 2014 Jul 26.

PMID:
25073664
19.

Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.

Van Schil PE, Baas P, Gaafar R, Maat AP, Van de Pol M, Hasan B, Klomp HM, Abdelrahman AM, Welch J, van Meerbeeck JP; European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group.

Eur Respir J. 2010 Dec;36(6):1362-9. doi: 10.1183/09031936.00039510. Epub 2010 Jun 4.

20.

Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma.

Gomez DR, Hong DS, Allen PK, Welsh JS, Mehran RJ, Tsao AS, Liao Z, Bilton SD, Komaki R, Rice DC.

J Thorac Oncol. 2013 Feb;8(2):238-45. doi: 10.1097/JTO.0b013e31827740f0.

PMID:
23247629
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk